Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C10H11N3O2S2 |
| Molecular Weight | 269.343 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=NSC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1
InChI
InChIKey=JVYKJZPZFIUYAB-UHFFFAOYSA-N
InChI=1S/C10H11N3O2S2/c1-7-6-10(16-12-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6,13H,11H2,1H3
| Molecular Formula | C10H11N3O2S2 |
| Molecular Weight | 269.343 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Sulfasomizole is a sulfanilamide derivative patented by Chemie Grunenthal G. m. b. H. as an antibiotic with broad-spectrum activity. Sulfasomizole is active against a wide range of gram-positive and gram-negative organisms. Sulfasomizole is well absorbed and distributed in the body, and is readily excreted in the urine.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.nature.com/articles/186221a0.pdf
1g
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:02:09 GMT 2025
by
admin
on
Mon Mar 31 18:02:09 GMT 2025
|
| Record UNII |
U3227B174V
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29739
Created by
admin on Mon Mar 31 18:02:09 GMT 2025 , Edited by admin on Mon Mar 31 18:02:09 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
U3227B174V
Created by
admin on Mon Mar 31 18:02:09 GMT 2025 , Edited by admin on Mon Mar 31 18:02:09 GMT 2025
|
PRIMARY | |||
|
C76980
Created by
admin on Mon Mar 31 18:02:09 GMT 2025 , Edited by admin on Mon Mar 31 18:02:09 GMT 2025
|
PRIMARY | |||
|
211-167-6
Created by
admin on Mon Mar 31 18:02:09 GMT 2025 , Edited by admin on Mon Mar 31 18:02:09 GMT 2025
|
PRIMARY | |||
|
3835
Created by
admin on Mon Mar 31 18:02:09 GMT 2025 , Edited by admin on Mon Mar 31 18:02:09 GMT 2025
|
PRIMARY | |||
|
CHEMBL2107088
Created by
admin on Mon Mar 31 18:02:09 GMT 2025 , Edited by admin on Mon Mar 31 18:02:09 GMT 2025
|
PRIMARY | |||
|
m943
Created by
admin on Mon Mar 31 18:02:09 GMT 2025 , Edited by admin on Mon Mar 31 18:02:09 GMT 2025
|
PRIMARY | Merck Index | ||
|
SUB10728MIG
Created by
admin on Mon Mar 31 18:02:09 GMT 2025 , Edited by admin on Mon Mar 31 18:02:09 GMT 2025
|
PRIMARY | |||
|
961
Created by
admin on Mon Mar 31 18:02:09 GMT 2025 , Edited by admin on Mon Mar 31 18:02:09 GMT 2025
|
PRIMARY | |||
|
69433
Created by
admin on Mon Mar 31 18:02:09 GMT 2025 , Edited by admin on Mon Mar 31 18:02:09 GMT 2025
|
PRIMARY | |||
|
DTXSID20212547
Created by
admin on Mon Mar 31 18:02:09 GMT 2025 , Edited by admin on Mon Mar 31 18:02:09 GMT 2025
|
PRIMARY | |||
|
139593
Created by
admin on Mon Mar 31 18:02:09 GMT 2025 , Edited by admin on Mon Mar 31 18:02:09 GMT 2025
|
PRIMARY | |||
|
632-00-8
Created by
admin on Mon Mar 31 18:02:09 GMT 2025 , Edited by admin on Mon Mar 31 18:02:09 GMT 2025
|
PRIMARY | |||
|
100000083298
Created by
admin on Mon Mar 31 18:02:09 GMT 2025 , Edited by admin on Mon Mar 31 18:02:09 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |